A significant breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This vital cancer inhibitor protein is frequently disabled in various types of cancer, causing https://linkedbookmarker.com/story7608163/mini-antibodies-restore-tumor-suppressor-p53-a-promising-approach-for-tumor-management